SBC Medical Launches Translation App Specialized Medical Aesthetics and Strengthens "Inbound-Focused Clinics" Initiative

Rhea-AI Summary

SBC Medical has launched a specialized translation app for medical aesthetics and implemented its 'Inbound-Focused Clinics' initiative to address growing medical tourism demand. The company currently serves over 10,000 inbound patients annually, with inquiries exceeding 20,000 yearly.

The global medical aesthetics market is projected to grow at a CAGR of 12.17% from 2024, reaching $212.5 billion by 2032. SBC has designated three flagship locations – Shinjuku Main Clinic, Shinbashi-Ginza Clinic, and Osaka Umeda Clinic – as inbound-focused facilities with English and Chinese-speaking concierges.

The company aims to double its annual inbound patient volume to 20,000 this year and plans to expand the initiative to additional cities including Yokohama, Nagoya, Sendai, and Sapporo. The translation app currently supports English and Chinese, with plans for expansion across all clinics nationwide.

Positive

• Current patient base of 10,000 inbound patients annually with 20,000+ inquiries
• Operating in a market projected to reach $212.5B by 2032 with 12.17% CAGR
• Strategic expansion to double patient volume to 20,000 annually
• Proprietary translation app development enhancing service capabilities

Negative

• None.

Insights

Market Research Analyst

The launch of SBC Medical's translation app and inbound-focused clinics initiative represents a strategic move to capitalize on the rapidly expanding medical tourism market. With the global medical aesthetics market projected to reach $212.5 billion by 2032 at a 12.17% CAGR, SBC is positioning itself to capture a significant share of this growth. The company's current base of 10,000 annual inbound patients and 20,000 yearly inquiries demonstrates strong existing demand, particularly from Chinese and English-speaking markets.

The implementation of dedicated inbound-focused clinics in strategic locations, coupled with the specialized translation app, addresses a critical market gap in medical tourism infrastructure. This expansion strategy, targeting key cities like Yokohama, Nagoya, Sendai and Sapporo, could significantly boost SBC's market penetration and revenue potential. The goal to double inbound patient volume to 20,000 this year appears ambitious but achievable given the market dynamics and infrastructure investments.

Tech Expert

The development of a specialized translation app for medical aesthetics showcases significant technological innovation in healthcare communication. Unlike generic translation tools, this purpose-built application addresses the unique challenges of medical terminology in aesthetics, potentially reducing liability risks from miscommunication and improving patient care quality. The initial bilingual support (English and Chinese) targets the highest-value market segments effectively, while the planned expansion to additional languages indicates scalable architecture.

The integration of dedicated language support systems within specific clinics, combined with the translation app, creates a comprehensive digital transformation of the patient experience. This tech-enabled approach to medical tourism could provide SBC with a sustainable competitive advantage in the Asian medical aesthetics market.

Healthcare Business Consultant

SBC's strategic focus on medical tourism infrastructure development represents a sophisticated approach to market expansion. By designating three flagship locations as inbound-focused clinics and planning expansion to additional cities, SBC is creating a scalable model for international patient care. The combination of technological solutions (translation app) with physical infrastructure (dedicated multilingual staff) addresses both operational efficiency and patient experience needs.

The business model leverages Japan's reputation for healthcare quality and hospitality, creating a differentiated value proposition in the competitive Asian medical tourism market. The potential revenue impact is substantial, considering the high-value nature of aesthetic procedures and the company's targeted doubling of inbound patients. This initiative could significantly enhance SBC's market position and financial performance in the growing medical tourism sector.

– Pioneering a New Era Where Global Patients Can Embrace Beauty and Confidence Through Japan's Cutting-Edge Medical Aesthetics –

TOKYO--(BUSINESS WIRE)-- Shonan Beauty Clinic, supported by SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical,” or the “Company”) in management services, today announced the launch of its proprietary translation app tailored for medical aesthetics staff and the full-scale implementation of its "Inbound-Focused Clinics" initiative. This groundbreaking move is designed to address the growing demand for medical tourism and ensure that international patients can seamlessly experience Japan's advanced medical aesthetic treatments.

Shonan Beauty Clinic, supported by SBC Medical Group Holdings Incorporated (Nasdaq: SBC) in management services, today announced the launch of its proprietary translation app tailored for medical aesthetics staff and the full-scale implementation of its "Inbound-Focused Clinics" initiative. This groundbreaking move is designed to address the growing demand for medical tourism and ensure that international patients can seamlessly experience Japan's advanced medical aesthetic treatments. (Photo: Business Wire)

Capitalizing on Medical Tourism’s Expanding Opportunities

The global medical aesthetics market is projected to grow at a compound annual growth rate (CAGR) of 12.17% from 2024, reaching $212.5 billion by 2032. Within Asia, rising awareness of aesthetic care and the increasing appeal of medical tourism are positioning countries like Japan, South Korea, and Thailand as top destinations for international patients. In Japan, the influx of foreign patients seeking high-quality medical aesthetics continues to rise. SBC alone welcomes over 10,000 inbound patients annually, with inquiries surpassing 20,000 each year. China remains a key market driver, though demand from English-speaking regions is also on the rise. Recognizing this trend, SBC is scaling up its operational capacity and implementing innovative solutions to support sustainable growth in this dynamic sector.

Revolutionizing Communication with a Specialized Translation App

To address language barriers, SBC has developed a state-of-the-art translation app tailored specifically for medical aesthetics. This app ensures the accurate translation of specialized terminology, facilitating seamless communication between clinic staff and international patients. Currently supporting English and Chinese, the app plays a pivotal role in enabling smooth consultations and pre-treatment explanations. By creating a welcoming environment where language is no obstacle, SBC empowers patients to feel secure and confident in their treatment choices. Future plans include expanding the app's language capabilities and rolling it out across all clinics nationwide, ensuring comprehensive accessibility for a global clientele.

"Inbound-Focused Clinics" to Drive Regional Development

SBC has designated three flagship locations – Shinjuku Main Clinic, Shinbashi-Ginza Clinic, and Osaka Umeda Clinic – as "Inbound-Focused Clinics." These facilities are staffed with dedicated English- and Chinese-speaking concierges, ensuring seamless, trustworthy communication. To further enhance accessibility, SBC plans to extend this initiative to key cities including Yokohama, Nagoya, Sendai, and Sapporo. With these measures in place, the company aims to double its annual inbound patient volume to 20,000 by this year.

A Vision for the Future: Medical Tourism as a "Beauty Infrastructure"

SBC’s mission transcends the delivery of aesthetic treatments. It strives to offer patients an unparalleled experience of "beauty" and "confidence" – values deeply rooted in Japan’s culture and technological excellence. By combining state-of-the-art medical aesthetics with the renowned warmth of Japanese hospitality, SBC is setting a new standard for tourism where healthcare, beauty, and culture intersect. This initiative not only boosts inbound tourism but also plays a vital role in regional revitalization and the broader growth of Japan’s medical tourism sector. Through its commitment to "delivering beauty beyond medicine," SBC continues to redefine the global landscape of medical aesthetics and inspire patients worldwide.

About SBC Medical

SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.

For more information, visit https://sbc-holdings.com/

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250120588355/en/

SBC Medical Group Holdings Incorporated

Hikaru Fukui / Head of Investor Relations

e-mail: ir@sbc-holdings.com

Source: SBC Medical Group Holdings Incorporated

FAQ

What is SBC Medical's target for inbound patient growth in its medical aesthetics clinics?

SBC Medical aims to double its annual inbound patient volume from 10,000 to 20,000 patients by this year through its Inbound-Focused Clinics initiative.

Which locations has SBC Medical designated as Inbound-Focused Clinics?

SBC Medical has designated three flagship locations as Inbound-Focused Clinics: Shinjuku Main Clinic, Shinbashi-Ginza Clinic, and Osaka Umeda Clinic.

What is the projected growth rate of the global medical aesthetics market according to SBC?

The global medical aesthetics market is projected to grow at a CAGR of 12.17% from 2024, reaching $212.5 billion by 2032.

What languages does SBC Medical's new translation app currently support?

SBC Medical's new translation app currently supports English and Chinese languages.

Which additional cities will SBC Medical expand its Inbound-Focused Clinics initiative to?

SBC Medical plans to expand its Inbound-Focused Clinics initiative to Yokohama, Nagoya, Sendai, and Sapporo.